phytosterols has been researched along with Infant--Premature--Diseases* in 2 studies
1 review(s) available for phytosterols and Infant--Premature--Diseases
Article | Year |
---|---|
The evolving use of intravenous lipid emulsions in the neonatal intensive care unit.
Parenteral nutrition and intravenous lipid emulsions are essential for promoting optimal nutrition in the neonatal intensive care unit. However, long-term use of a pure soybean lipid emulsion is associated with a liver disease known as intestinal failure associated liver disease. Over the past several years, the science of lipid emulsions has evolved with a focus on nutritional optimization and disease prevention. This review's purpose is to provide a general overview of the three main components of lipid emulsions, phytosterols, the antioxidant Vitamin E, and polyunsaturated fatty acids, and their contribution to health. Topics: Dietary Fats; Fat Emulsions, Intravenous; Gastrointestinal Diseases; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Intestinal Absorption; Intestines; Liver Diseases; Parenteral Nutrition; Phytosterols; Randomized Controlled Trials as Topic; Risk Assessment; Soybean Oil; Vitamin E | 2019 |
1 trial(s) available for phytosterols and Infant--Premature--Diseases
Article | Year |
---|---|
The effect of 5 intravenous lipid emulsions on plasma phytosterols in preterm infants receiving parenteral nutrition: a randomized clinical trial.
Elevated plasma phytosterol concentrations are an untoward effect of parenteral nutrition (PN) with vegetable oil-based lipid emulsions (LEs). Phytosterols are elevated in neonatal cholestasis, but the relation remains controversial.. The objective was to study the effect of 5 LEs on plasma phytosterols in preterm infants.. One hundred forty-four consecutive admitted preterm infants (birth weight: 500-1249 g) were studied. Patients were randomly assigned to receive 1 of 5 different LEs: S [100% soybean oil (SO)], MS [50% medium-chain triglycerides (MCTs) and 50% SO], MSF (50% MCTs, 40% SO, and 10% fish oil (FO)], OS (80% olive oil and 20% SO), or MOSF (30% MCTs, 25% olive oil, 30% SO, and 15% FO). Phytosterols in the LEs and in plasma (on postnatal day 7 and day 14) were measured by gas chromatography-mass spectrometry.. Patients in the S group had significantly higher total phytosterol intakes than did the other study groups. On PN days 7 and 14, plasma phytosterol concentrations were highest in the S group and lowest in the MOSF group. Despite similar β-sitosterol intakes between the MS and MSF groups, plasma concentrations were significantly lower in the MSF than in the MS group. Only 3 patients (2.1%) developed cholestasis: 1 in the MS, 1 in the MSF, and 1 in the MOSF group. No cases of cholestasis were observed in the S and OS groups.. In uncomplicated preterm infants receiving routine PN, we found a correlation between phytosterol intake and plasma phytosterol concentrations; however, cholestasis was rare and no difference in liver function at 6 wk was observed. Topics: Birth Weight; Cholestasis; Emulsions; Fat Emulsions, Intravenous; Female; Fish Oils; Gas Chromatography-Mass Spectrometry; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Liver; Male; Olive Oil; Parenteral Nutrition; Phytosterols; Plant Oils; Sitosterols; Soybean Oil; Triglycerides | 2013 |